Fibroblast Growth Factor 21 Correlates with the Prognosis of Dilated Cardiomyopathy.

Gu, Lingyun; Jiang, Wenlong; Zheng, Ruolong; Yao, Yuyu; Ma, Genshan

Gu, Lingyun; Jiang, Wenlong; Zheng, Ruolong; Yao, Yuyu; Ma, Genshan.

Afiliação

Gu L; Department of Cardiology, Zhongda Hospital, Medical School of Southeast University, Nanjing, China, lingygapple@163.com.
Jiang W; Department of Cardiology, Jiangyin Hospital Affiliated to Southeast University, Jiangyin, China, lingygapple@163.com.
Zheng R; Department of Cardiology, Jiangyin Hospital Affiliated to Southeast University, Jiangyin, China.
Yao Y; Department of Cardiology, Jiangyin Hospital Affiliated to Southeast University, Jiangyin, China.
Ma G; Department of Cardiology, Zhongda Hospital, Medical School of Southeast University, Nanjing, China.

Cardiology ; 146(1): 27-33, 2021.

Article em En | MEDLINE | ID: mdl-33264784

Assuntos

Cardiomiopatia Dilatada; Fatores de Crescimento de Fibroblastos; Insuficiência Cardíaca; Biomarcadores; Cardiomiopatia Dilatada/diagnóstico por imagem; Humanos; Peptídeo Natriurético Encefálico; Fragmentos de Peptídeos; Prognóstico; Volume Sistólico; Função Ventricular Esquerda

Palavras-chave

Dilated cardiomyopathy; Fibroblast growth factor 21; Heart failure; Prognosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cardiomiopatia Dilatada / Fatores de Crescimento de Fibroblastos / Insuficiência Cardíaca Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google